Cellectis Other Current Liab from 2010 to 2024

CLLS Stock  USD 2.13  0.01  0.47%   
Cellectis Other Current Liabilities yearly trend continues to be comparatively stable with very little volatility. Other Current Liabilities will likely drop to about 11.7 M in 2024. From the period from 2010 to 2024, Cellectis Other Current Liabilities quarterly data regression had r-value of  0.67 and coefficient of variation of  63.72. View All Fundamentals
 
Other Current Liabilities  
First Reported
2008-12-31
Previous Quarter
10.1 M
Current Value
10.6 M
Quarterly Volatility
15.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cellectis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cellectis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 19.4 M, Interest Expense of 6.7 M or Selling General Administrative of 30.4 M, as well as many indicators such as Price To Sales Ratio of 223, Dividend Yield of 0.0 or PTB Ratio of 3.61. Cellectis financial statements analysis is a perfect complement when working with Cellectis Valuation or Volatility modules.
  
Check out the analysis of Cellectis Correlation against competitors.

Latest Cellectis' Other Current Liab Growth Pattern

Below is the plot of the Other Current Liab of Cellectis SA over the last few years. It is Cellectis' Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cellectis' overall financial position and show how it may be relating to other accounts over time.
Other Current Liab10 Years Trend
Slightly volatile
   Other Current Liab   
       Timeline  

Cellectis Other Current Liab Regression Statistics

Arithmetic Mean10,626,941
Geometric Mean3,354,560
Coefficient Of Variation63.72
Mean Deviation4,921,392
Median10,519,484
Standard Deviation6,771,041
Sample Variance45.8T
Range25.6M
R-Value0.67
Mean Square Error27.3T
R-Squared0.45
Significance0.01
Slope1,011,709
Total Sum of Squares641.9T

Cellectis Other Current Liab History

202411.7 M
202312.1 M
202225.6 M
202114.6 M
202020.2 M
201912.2 M
20189.9 M

About Cellectis Financial Statements

Cellectis shareholders use historical fundamental indicators, such as Other Current Liab, to determine how well the company is positioned to perform in the future. Although Cellectis investors may analyze each financial statement separately, they are all interrelated. The changes in Cellectis' assets and liabilities, for example, are also reflected in the revenues and expenses on on Cellectis' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Current Liabilities12.1 M11.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cellectis Stock Analysis

When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.